Gilead Sciences, Inc. (GILD) stock
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/30104% above fair value
$168.08+0.13 (+0.08%)
Close on Nov 13, 2026Market cap $208.48BP/E –Yield 1.88%
Gilead Sciences statistics
102 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 9, 2027 (estimated, after the close)
- Last ex-dividend date
- Dec 15, 2026
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/OCF Ratio
- 14.40
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 7.36
- 2.57
- EV / FCF
- 16.56
- 22.27
Share statisticsIndustry
- Shares Change (YoY)
- -0.93%
- 10.8%
- Shares Change (QoQ)
- 0.00%
- 0.50%
- Float
- 1.24B
- 49M
- Shares Held by Insiders
- 0.10%
- 11.7%
- Shares Held by Institutions
- 89.8%
- 56.4%
Short sellingIndustry
- Short Interest
- 21M
- –
- Short Interest Change
- 4.94%
- -0.80%
- Short % of Float
- 1.72%
- 9.01%
- Short % of Shares Outstanding
- 1.72%
- 6.30%
- Days to Cover
- 3.18
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $176.58
- –
- 52-Week Low
- $116.88
- –
- 20-Day Moving Average
- $164.12
- –
- 50-Day Moving Average
- $155.10
- –
- 200-Day Moving Average
- $141.72
- –
- Average True Range (14)
- $4.55
- –
- Price Change (1 Week)
- 0.71%
- -1.15%
- Price Change (1 Month)
- 6.81%
- -4.87%
- Price Change (3 Months)
- 21.0%
- -21.0%
- Price Change (6 Months)
- 29.7%
- -20.6%
- Price Change (YTD)
- 36.9%
- -23.6%
- Price Change (1 Year)
- 36.2%
- -22.4%
- Price Change (3 Years)
- 124.9%
- -29.5%
- Price Change (5 Years)
- 149.1%
- -77.9%
- Price Change (10 Years)
- 119.0%
- -65.4%
- Average Volume (10 Days)
- 6M
- –
- Average Volume (20 Days)
- 7M
- –
- Average Volume (90 Days)
- 6M
- –
- Relative Volume
- 0.59
- 0.70
- Relative Strength Index (14)
- 59.3
- 43.4
- Volatility (1 Year)
- 27.3%
- 80.1%
- Beta (5 Years)
- 0.43
- 1.07
MarginsIndustry
- Pretax Margin
- -8.17%
- -11.6%
- EBITDA Margin
- -7.62%
- -27.7%
- FCF Margin
- 44.5%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -22.3%
- -49.9%
- Return on Assets (ROA)
- -7.03%
- -40.6%
- Return on Invested Capital (ROIC)
- -5.19%
- -32.9%
- Return on Capital Employed (ROCE)
- -5.99%
- -37.9%
Financial positionIndustry
- Current Ratio
- 1.38
- 3.30
- Quick Ratio
- 0.95
- 2.39
- Debt / Equity
- 2.01
- 0.49
- Debt / FCF
- 1.90
- 4.65
- Interest Coverage
- -2.34
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 6.54%
- 6.82%
- Net Income Growth (YoY)
- -147.6%
- -14.4%
- EPS Growth (YoY)
- -149.2%
- -12.3%
- FCF Growth (YoY)
- 50.4%
- 6.85%
- Revenue Growth (3Y CAGR)
- 2.57%
- 2.25%
- Revenue Growth (5Y CAGR)
- 3.58%
- 6.41%
- EPS Growth (3Y CAGR)
- 23.0%
- 1.30%
- EPS Growth (5Y CAGR)
- 132.4%
- 3.78%
EfficiencyIndustry
- Asset Turnover
- 0.56
- 0.40
- Inventory Turnover
- 3.38
- 2.73
- Revenue Per Employee
- $1.82M
- $429.29K
- Profits Per Employee
- -$227.24K
- -$689.41K
- Employee Count
- 17,000
- 74
- WACC
- 7.20%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$2.53B
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- -$19.79B
- $17.76M
- Net Cash Per Share
- -$15.96
- $0.80
- Equity (Book Value)
- $13.04B
- $53.89M
- Book Value Per Share
- $10.51
- $1.50
- Tangible Book Value
- -$8.70B
- $27.13M
- Working Capital
- $4.55B
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$699.00M
- -$1.00M
- FCF Per Share
- $11.11
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -1.85%
- -21.8%
- FCF Yield
- 6.61%
- -9.44%
- Dividend Yield
- 1.88%
- 1.88%
- Buyback Yield
- 0.52%
- -0.76%
- Shareholder Yield
- 2.40%
- 0.00%
- Dividend Per Share
- $3.16
- $0.83
- Dividend Growth (YoY)
- 2.60%
- 2.37%
- Years of Dividend Growth
- 11
- 0
- FCF Payout Ratio
- 29.8%
- 43.7%
Taxes and interestIndustry
- Interest Expense
- $1.01B
- $2.90M
- Income Tax
- $1.33B
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- 3.89
- 0.23
- Piotroski F-Score
- 8
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | GILD | S&P 500 | Difference | GILD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +13.6% | -3.0% | +16.7 pts | ||
| 3 months | +22.4% | -2.8% | +25.1 pts | ||
| Year to date | +39.4% | +11.5% | +27.9 pts | ||
| 1 year | +37.6% | +13.5% | +24.1 pts | ||
| 3 years | +146.6% | +77.7% | +68.9 pts | +35.1% | +21.1% |
| 5 years | +197.6% | +72.6% | +125.0 pts | +24.4% | +11.5% |
| 10 years | +213.3% | +308.2% | −94.9 pts | +12.1% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
21M GILD shares were sold short on Oct 30, 2026, up 4.9% from the previous report, or 1.72% of the shares available to trade. At recent volumes it would take 3.2 days to buy them back. Over the last 20 sessions, 45.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 21,271,970 | +4.9% | 6,696,858 | 3.2 |
| Oct 15, 2026 | 20,270,007 | -7.1% | 5,454,083 | 3.7 |
| Sep 30, 2026 | 21,828,725 | +19.3% | 6,503,853 | 3.4 |
| Sep 15, 2026 | 18,304,875 | -20.4% | 5,017,110 | 3.6 |
| Aug 31, 2026 | 23,007,029 | -0.8% | 5,438,943 | 4.2 |
| Aug 14, 2026 | 23,183,970 | -4.9% | 7,146,553 | 3.2 |
| Jul 31, 2026 | 24,385,621 | -3.5% | 6,312,993 | 3.9 |
| Jul 15, 2026 | 25,261,911 | -0.9% | 6,888,646 | 3.7 |
| Jun 30, 2026 | 25,484,358 | +6.8% | 9,596,162 | 2.7 |
| Jun 15, 2026 | 23,861,932 | -7.2% | 8,868,841 | 2.7 |
| May 29, 2026 | 25,725,417 | +11.2% | 6,740,926 | 3.8 |
| May 15, 2026 | 23,135,379 | +0.4% | 6,501,415 | 3.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?